The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

A new study has made the case for synching your daily calories with your own circadian rhythm to improve glucose metabolism, ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

Obesity medications, once facing shortages, are now widely available. So how do consumers not get scammed into purchasing ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

This segment is sponsored by Eli Lilly and Company.Social media is flooded with advertisments for popular obestiy medications ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.